Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control ...
Stocktwits on MSN
Capricor Therapeutics Stock Becomes Talk Of Retail Town On DMD Study; Retail Sees New Hope After Sarepta Setback
Capricor’s peer-reviewed publication in Biomedicines reinforced the scientific foundation of its Duchenne therapy Deramiocel, ...
Capricor Therapeutics (CAPR) announced the publication in Biomedicines, an international peer-reviewed journal, describing a novel in-vitro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback